Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes

Journal of Bone and Mineral Research

Volumn 31, Issue 6, 2016, Pages 1128-1136

  Denburg, Michelle R ^a   Hoofnagle, Andrew N ^b   Sayed, Samir ^c   Gupta, Jayanta ^d   De Boer, Ian H ^e   Appel, Lawrence J ^f   Durazo Arvizu, Ramon ^g   Whitehead, Krista ^a   Feldman, Harold I ^a,h   Leonard, Mary B ⁱ  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Washingon University School of Medicine   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Texas Tech University Health Sciences Center El Paso   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BIOAVAILABLE Vitamin D; Gc; GENOTYPE; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; Vitamin D BINDING PROTEIN

Indexed keywords

VITAMIN D BINDING PROTEIN; ISOPROTEIN; VITAMIN D;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MONOCLONAL ENZYME LINKED IMMUNOSORBENT ASSAY; POLYCLONAL ENZYME LINKED IMMUNOSORBENT ASSAY; RACE DIFFERENCE; TANDEM MASS SPECTROMETRY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; MASS SPECTROMETRY; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOZYGOTE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84971577094     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2829     Document Type: Article

References (52)

1. Hirschfeld J., Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol Scand. 1959; 47: 160-8.
2. Haddad JG, Hu YZ, Kowalski MA, et al., Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry. 1992; 31: 7174-81.
3. Otterbein LR, Cosio C, Graceffa P, Dominguez R., Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc Natl Acad Sci U S A. 2002; 99: 8003-8.
4. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C., A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol. 2002; 9: 131-6.
5. Zhang J, Habiel DM, Ramadass M, Kew RR., Identification of two distinct cell binding sequences in the vitamin D binding protein. Biochim Biophys Acta. 2010; 1803: 623-9.
6. Bhan I, Powe CE, Berg AH, et al., Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012; 82: 84-9.
7. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG., Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63: 954-9.
8. Bikle DD, Siiteri PK, Ryzen E, Haddad JG., Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985; 61: 969-75.
9. Feldman D, Malloy PJ, Gross C., Vitamin D: biology, action, and clinical implications. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 2nd ed. New York: Academic Press; 2001. p. 257-303.
10. White P, Cooke N., The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000; 11: 320-7.
11. Bikle DD, Gee E., Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology. 1989; 124: 649-54.
12. Chun RF, Lauridsen AL, Suon L, et al., Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 2010; 95: 3368-76.
13. Braun A, Bichlmaier R, Cleve H., Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum Genet. 1992; 89: 401-6.
14. Arnaud J, Constans J., Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993; 92: 183-8.
15. Constans J, Hazout S, Garruto RM, Gajdusek DC, Spees EK., Population distribution of the human vitamin D binding protein: anthropological considerations. Am J Phys Anthropol. 1985; 68: 107-22.
16. Kamboh MI, Ferrell RE., Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet. 1986; 72: 281-93.
17. Speeckaert MM, Speeckaert R, van Geel N, Delanghe JR., Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem. 2014; 63: 1-57.
18. Anic GM, Weinstein SJ, Mondul AM, Mannisto S, Albanes D., Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer. 2014; 86: 297-303.
19. Anic GM, Weinstein SJ, Mondul AM, Mannisto S, Albanes D., Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One. 2014; 9: e102966.
20. Bratke K, Wendt A, Garbe K, et al., Vitamin D binding protein and vitamin D in human allergen-induced endobronchial inflammation. Clin Exp Immunol. 2014; 177: 366-72.
21. Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P., Influence of vitamin D binding protein on accuracy of 25-hydroxyvitamin D measurement using the ADVIA centaur vitamin D total assay [erratum]. Int J Endocrinol. 2014; 2014: 691679.
22. Hiemstra TF, Casian A, Boraks P, Jayne DR, Schoenmakers I., Plasma exchange induces vitamin D deficiency. QJM. 2014; 107: 123-30.
23. Ikeda T, Kasai M, Tatsukawa E, et al., A bone substitute with high affinity for vitamin D-binding protein - relationship with niche of osteoclasts. J Cell Mol Med. 2014; 18: 170-80.
24. Kalousova M, Dusilova-Sulkova S, Zakiyanov O, et al., Vitamin D binding protein is not involved in vitamin D deficiency in patients with chronic kidney disease [erratum]. BioMed Res Int. 2015; 2015: 492365.
25. Lai JC, Bikle DD, Lizaola B, Hayssen H, Terrault NA, Schwartz JB., Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int. 2015; 35 (10): 2294-300.
26. Mondul AM, Weinstein SJ, Moy KA, Mannisto S, Albanes D., Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int J Cancer. 2014; 134: 2699-706.
27. Ponda MP, McGee D, Breslow JL., Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial. J Clin Endocrinol Metab. 2014; 99: 2494-9.
28. Rousseau AF, Damas P, Janssens M, et al., Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D ? Clin Chim Acta. 2014; 437: 43-7.
29. Shoukry A, Bdeer SE, El-Sokkary RH., Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem. 2015;408(1-2): 25-35.
30. Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R., Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Mult Scler. 2014; 20: 433-7.
31. Tian XQ, Zhao LM, Ge JP, Zhang Y, Xu YC. Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy. Exp Ther Med. 2014; 7: 411-6.
32. Wilson RT, Bortner JD Jr, Roff A, et al., Genetic and environmental influences on plasma vitamin D binding protein concentrations. Transl Res. 2015; 165: 667-76.
33. Schwartz JB, Lai J, Lizaola B, et al., A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab. 2014; 99: 1631-7.
34. Powe CE, Evans MK, Wenger J, et al., Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369: 1991-2000.
35. Bouillon R, Jones K, Schoenmakers I., Vitamin D-binding protein and vitamin D in blacks and whites [comment]. N Engl J Med. 2014; 370: 879.
36. Carter GD, Phinney KW., Assessing vitamin D status: time for a rethink ? Clin Chem. 2014; 60: 809-11.
37. Hollis BW, Bikle DD., Vitamin D-binding protein and vitamin D in blacks and whites [comment]. N Engl J Med. 2014; 370: 879-80.
38. Jemielita TO, Leonard MB, Baker J, et al., Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int. 2016; 27 (2): 617-26.
39. Henderson CM, Lutsey PL, Misialek JR, et al., Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D binding protein in blacks and whites. Clin Chem. 2016; 62 (1): 179-87.
40. Feldman HI, Appel LJ, Chertow GM, et al., The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003; 14: S148-53.
41. Gao Y, Wu K, Xu Y, et al., Characterization of acute renal allograft rejection by human serum proteomic analysis. J Huazhong Univ Sci Technolog Med Sci. = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2009; 29: 585-91.
42. Powe CE, Ricciardi C, Berg AH, et al., Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011; 26: 1609-16.
43. Vermeulen A, Verdonck L, Kaufman JM., A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84: 3666-72.
44. Lin LI., A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989; 45: 255-68.
45. Bouillon R, van Baelen H, de Moor P., The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab. 1977; 45: 225-31.
46. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, Bouillon R, Lissens W, Amery A., Calcium, vitamin D-endocrine system, and parathyroid hormone in black and white males. Calcif Tissue Int. 1987; 41: 70-4.
47. Winters SJ, Chennubhatla R, Wang C, Miller JJ., Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism. 2009; 58: 438-42.
48. Lauridsen AL, Vestergaard P, Nexo E., Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem. 2001; 47: 753-6.
49. Christiansen M, Jorgensen CS, Laursen I, Hirschberg D, Hojrup P, Houen G., Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochim Biophys Acta. 2007; 1774: 481-92.
50. Powe CE, Karumanchi SA, Thadhani R., Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014; 370: 880-1.
51. Denburg MR, Kalkwarf HJ, de Boer IH, et al., Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol. 2013; 28: 1843-53.
52. Denburg MR, Tsampalieros AK, de Boer IH, et al., Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab. 2013; 98: 1930-8.